34641594|t|Curcumin Loaded Dendrimers Specifically Reduce Viability of Glioblastoma Cell Lines.
34641594|a|Glioblastoma (GB) is a deadly and aggressive cancer of the CNS. Even with extensive resection and chemoradiotherapy, patient survival is still only 15 months. To maintain growth and proliferation, cancer cells require a high oxidative state. Curcumin, a well-known anti-inflammatory antioxidant, is a potential candidate for treatment of GB. To facilitate efficient delivery of therapeutic doses of curcumin into cells, we encapsulated the drug in surface-modified polyamidoamine (PAMAM) dendrimers. We studied the in vitro effectiveness of a traditional PAMAM dendrimer (100% amine surface, G4 NH2), surface-modified dendrimer (10% amine and 90% hydroxyl-G4 90/10-Cys), and curcumin (Cur)-encapsulated dendrimer (G4 90/10-Cys-Cur) on three species of glioblastoma cell lines: mouse-GL261, rat-F98, and human-U87. Using an MTT assay for cell viability, we found that G4 90/10-Cys-Cur reduced viability of all three glioblastoma cell lines compared to non-cancerous control cells. Under similar conditions, unencapsulated curcumin was not effective, while the non-modified dendrimer (G4 NH2) caused significant death of both cancerous and normal cells. By harnessing and optimizing the components of PAMAM dendrimers, we are providing a promising new route for delivering cancer therapeutics. Our results with curcumin suggest that antioxidants are good candidates for treating glioblastoma.
34641594	0	8	Curcumin	Chemical	MESH:D003474
34641594	16	26	Dendrimers	Chemical	MESH:D050091
34641594	60	72	Glioblastoma	Disease	MESH:D005909
34641594	85	97	Glioblastoma	Disease	MESH:D005909
34641594	99	101	GB	Disease	MESH:D005909
34641594	130	147	cancer of the CNS	Disease	MESH:D009369
34641594	202	209	patient	Species	9606
34641594	282	288	cancer	Disease	MESH:D009369
34641594	327	335	Curcumin	Chemical	MESH:D003474
34641594	355	367	inflammatory	Disease	MESH:D007249
34641594	423	425	GB	Disease	MESH:D005909
34641594	484	492	curcumin	Chemical	MESH:D003474
34641594	550	564	polyamidoamine	Chemical	MESH:C531249
34641594	566	571	PAMAM	Chemical	MESH:C531249
34641594	573	583	dendrimers	Chemical	MESH:D050091
34641594	640	645	PAMAM	Chemical	MESH:C531249
34641594	646	655	dendrimer	Chemical	MESH:D050091
34641594	662	667	amine	Chemical	MESH:D000588
34641594	677	683	G4 NH2	Chemical	-
34641594	703	712	dendrimer	Chemical	MESH:D050091
34641594	718	723	amine	Chemical	MESH:D000588
34641594	732	740	hydroxyl	Chemical	MESH:D017665
34641594	741	743	G4	Chemical	MESH:D004003
34641594	750	753	Cys	Chemical	MESH:D003545
34641594	760	768	curcumin	Chemical	MESH:D003474
34641594	770	773	Cur	Chemical	MESH:D003474
34641594	788	797	dendrimer	Chemical	MESH:D050091
34641594	799	801	G4	Chemical	MESH:D004003
34641594	805	815	10-Cys-Cur	Chemical	-
34641594	837	849	glioblastoma	Disease	MESH:D005909
34641594	862	867	mouse	Species	10090
34641594	868	873	GL261	CellLine	CVCL:Y003
34641594	875	878	rat	Species	10116
34641594	879	882	F98	CellLine	CVCL:3510
34641594	888	893	human	Species	9606
34641594	894	897	U87	CellLine	CVCL:0022
34641594	908	911	MTT	Chemical	MESH:C070243
34641594	952	958	G4 90/	Chemical	-
34641594	958	968	10-Cys-Cur	Chemical	-
34641594	1000	1012	glioblastoma	Disease	MESH:D005909
34641594	1106	1114	curcumin	Chemical	MESH:D003474
34641594	1157	1166	dendrimer	Chemical	MESH:D050091
34641594	1168	1174	G4 NH2	Chemical	-
34641594	1284	1289	PAMAM	Chemical	MESH:C531249
34641594	1290	1300	dendrimers	Chemical	MESH:D050091
34641594	1356	1362	cancer	Disease	MESH:D009369
34641594	1394	1402	curcumin	Chemical	MESH:D003474
34641594	1462	1474	glioblastoma	Disease	MESH:D005909
34641594	Negative_Correlation	MESH:C531249	MESH:D009369
34641594	Negative_Correlation	MESH:D003474	MESH:D007249
34641594	Negative_Correlation	MESH:D003474	MESH:D005909

